Covid-19 patients with a first-phase ejection fraction -- a measure of the left ventricular ejection fraction until the time of maximal ventricular contraction -- of less than 25 per cent had a nearly five-fold higher risk of death than those with an ejection fraction of 25 per cent or higher.
